ProShare Advisors
CLBT icon

ProShare Advisors’s Cellebrite CLBT Stock Holding History

ProShare Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
17,461
+3,714
+27% +$49.1K ﹤0.01% 1514
2026
Q1 		$189K Buy
13,747
+1,058
+8% +$15.9K ﹤0.01% 1607
2025
Q4 		$229K Buy
+12,689
New +$228K ﹤0.01% 1624

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

ProShare Advisors's CLBT Position: Q2 2026 in Review

ProShare Advisors increased its Cellebrite (CLBT) stake by 27% in Q2 2026, buying an estimated $49.1K and bringing the position to 17,461 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

ProShare Advisors first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • ProShare Advisors held 17,461 shares of Cellebrite worth $255K as of Q2 2026.
  • ProShare Advisors bought 3,714 Cellebrite shares in Q2 2026, an estimated $49.1K.
  • Cellebrite made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1514 holding.
  • ProShare Advisors first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.